Inhibitor analysis for Alzheimer’s points towards a polypharmacology approach: abstract highlights from PharmSci360 day 3
What research is being presented at AAPS PharmSci360 (3–6 November 2019; TX, USA)? We bring you some of our highlights, including how repurposing an antipsychotic drug could be used to treat metastatic breast cancer and a Dual-acting inhibitor that can target opportunistic bacterium.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>